Received Apr 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 2 | UNK | — |
fatigue; loss of appetite; fever; Headache; sick; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of fatigue in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Previously administered products included Shingrix (received first dose of Shingrix on an unknown date). On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced fatigue (Verbatim: fatigue), appetite lost (Verbatim: loss of appetite), fever (Verbatim: fever), headache (Verbatim: Headache) and sickness (Verbatim: sick). The outcome of the fatigue, appetite lost, fever and headache were not reported and the outcome of the sickness was resolved (duration 2 days). It was unknown if the reporter considered the fatigue, appetite lost, fever, headache and sickness to be related to Shingles vaccine. It was unknown if the company considered the fatigue, appetite lost, fever, headache and sickness to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 17-APR-2025 This case was reported by a patient via interactive digital media. The husband had 2nd shot. He was sick for 2 days. Had stomach loss of appetite, fever, headache and fatigue all day.